Efficiency of Intermittent Hypoxia Intervention in Primary Insomnia (NCT07394699) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Efficiency of Intermittent Hypoxia Intervention in Primary Insomnia
30 participantsStarted 2026-04-01
Plain-language summary
The purpose of this study was to understand the effectiveness of intermittent hypoxia in the treatment of primary insomnia.
Who can participate
Age range18 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjects are diagnosed with primary insomnia between 18 and 60 years old,gender is not limited.
* Patients who are not taking sedative-hypnotic drugs or have stopped taking drugs for more than 2 weeks.
* Residing in the plains all year round and not having been above 1500 meters above sea level in the past 30 days.
* Quiet state SaO2 ≥ 90%, cerebral oxygen saturation 58-82%, heart rate 60-100 beats/min, blood pressure 90-140/60-90 mmHg, respiratory rate 16-20 times/min.
* No functional drinks, caffeine-containing beverages, or sleep-disturbing medications during the study period.
Exclusion Criteria:
* Stroke onset in the past 3 months, other severe neurological diseases, such as epilepsy, intracranial infectious diseases or demyelination.
* Uncontrolled hypertension (systolic blood pressure ≥200mmHg) with antihypertensive drugs before enrollment, other cardiovascular diseases.
* History of pulmonary, hepatic, dermatologic, or hematologic diseases.
* History of substance abuse.
* Pregnancy, Severe sleep apnea and neurological disorders.
What they're measuring
1
The polysomnography between IH group and control group